
Hello manoj kumar valluru,
Last week an interesting news story about >20 Texan patients treated with stem cells suffering from multiple sclerosis came out. We watch these developments with cautious optimism. Click here for the video.
A recent paper describing TNF-alpha inhibiting SDF-1 secretion was published. This may explain some of the osteoclastic effects seen in patients with chronic inflammation. Another interesting finding was that EPO can inhibit the mouse model of multiple sclerosis through stimulation of Treg and inhibition of Th17. Maybe this is why some cancer patients do worse if they are on chronic EPO?
Two neat patents came out last week. #7,494,644 covers the transfection of cells (myoblasts and mesenchymal) with connexin-43 to increase their ability to interact with myocardium. This could be a great way of overcoming arrythmias seen with some myoblast-based approaches. Irv Weissman continues his patent domination of the field of hematology, getting a patent on the megakaryocytic progenitor (#7,494,807). He is inventor on the common myeloid progenitor, as well as common lymphoid progenitor patents. Great job Irv !
Although the majority of studies looking at stem cell mediated immune modulation have been focused on mesenchymal stem cells, a recent paper describes suppression of the mouse model of MS through administration of hematopoietic stem cells, and demonstrated that therapeutic effect was associated with upregulation of indolamine 2,3 deoxygenase in the dendritic cells.
It is known that bone marrow stem cells are mobilized after heart injury such as infarct, with presumable therapeutic effects mediated by the stem cells in terms of stimulating angiogenesis or even integrating into the damaged myocardium and transdifferentiating into de novo The use of stem cells for treatment of multiple sclerosis has the potential to address both the inflammatory aspects of the disease, as well as induce regeneration. Above is a clip from a news release describing what appears to be a repeatedly... Ask a question OR leave your comments.
Methods and compositions for correction of cardiac conduction disturbances
Stem Cell Therapy for Multiple Sclerosis
Media Partnerships (NEW)
LATEST NEWS
Leptin Blocks T Regulatory Cell Expansion
August 23rd, 2009
Mechanism of Multiple Sclerosis Stem Cell Therapy
July 24th, 2009
:
2 Comments
Lithium for Treatment of Multiple Sclerosis
July 15th, 2009
Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells
July 9th, 2009
:
2 Comments
Apoptotic Cells Secrete Angiogenic Factors
June 27th, 2009
Read more news on StemCellPatents.com
LATEST JOBS POSTS
View the StemCellPatents.com Job Board
Thanks again for your help in supporting StemCellPatents.com.
Media Partnerships (NEW)